Ads
related to: euro lupus guidelines cancer risk reduction tool- Causes Of Lupus Nephritis
Visit To Learn More About The
Causes Of Lupus Nephritis Today.
- Learn About Lupus
Discover Symptoms, Triggers, & How
Lupus Affects The Immune System.
- Lupus Tools & Resources
Find Tools, Videos And Resources
To Help You Understand Lupus.
- See Possible Side Effects
See Possible Side Effects For A
Lupus Nephritis Treatment Option.
- Answers From A Doctor
Watch Doctors Q&A Videos.
Listen To Dr Talk About Lupus.
- Coverage & Co-Pay Info
See If You're Eligible To Save On
Treatment & Find Coverage Info.
- Causes Of Lupus Nephritis
Search results
Results From The WOW.Com Content Network
Belimumab, sold under the brand name Benlysta, is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), [6] also known as B-lymphocyte stimulator (BLyS). [7] It is approved in the United States [8] and Canada, [9] and the European Union [5] to treat systemic lupus erythematosus and lupus nephritis.
Lupus erythematosus is a collection of autoimmune diseases in which the human immune system becomes hyperactive and attacks healthy tissues. [1] Symptoms of these diseases can affect many different body systems, including joints, skin, kidneys, blood cells, heart, and lungs. The most common and most severe form is systemic lupus erythematosus.
2–7 per 10,000 [2] Lupus, technically known as systemic lupus erythematosus (SLE), is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. [1] Symptoms vary among people and may be mild to severe. [1] Common symptoms include painful and swollen joints, fever, chest pain, hair ...
Cyclophosphamide (CP), also known as cytophosphane among other names, [3] is a medication used as chemotherapy and to suppress the immune system. [4] As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma. [4]
Tacrolimus, sold under the brand name Prograf among others, is an immunosuppressive drug. After allogenic organ transplant, the risk of organ rejection is moderate. To lower the risk of organ rejection, tacrolimus is given. The drug can also be sold as a topical medication in the treatment of T-cell-mediated diseases such as eczema and psoriasis.
Lupus anticoagulant. Lupus anticoagulant is an immunoglobulin [1] that binds to phospholipids and proteins associated with the cell membrane. Its name is a partial misnomer, as it is actually a prothrombotic antibody in vivo. The name derives from their properties in vitro, as these antibodies increase coagulation times in laboratory tests such ...
Subacute cutaneous lupus erythematosus. Subacute cutaneous lupus erythematosus (SCLE ) is a clinically distinct subset of cases of lupus erythematosus that is most often present in white women aged 15 to 40, consisting of skin lesions that are scaly and evolve as poly-cyclic annular lesions or plaques similar to those of plaque psoriasis. [1]
The European Journal of Cancer Prevention (print: ISSN 0959-8278, online: ISSN 1473-5709) is the official journal of the European Cancer Prevention Organization. It was established in 1991 and is published bimonthly by Lippincott Williams & Wilkins. The journal focuses on raising awareness of the various forms of cancer prevention as well as ...
Ad
related to: euro lupus guidelines cancer risk reduction tool